Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,871Revenue $M30.7Net Margin (%)-270.6Z-Score21.2
Enterprise Value $M1,704EPS $-0.4Operating Margin %-273.0F-Score3
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-270.6Higher ROA y-yY
Price/Book8.510-y EBITDA Growth Rate %-0.6Quick Ratio5.5Cash flow > EarningsY
Price/Sales57.45-y EBITDA Growth Rate %-3.8Current Ratio5.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-31.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)7ROE % (ttm)-35.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M239ROI % (ttm)-57.0Gross Margin Increase y-yN

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVAXJean-Marie Eveillard 2014-12-31 Sold Out -0.01%$4.05 - $5.98
($5.23)
$ 7.9534%Sold Out0
NVAXJean-Marie Eveillard 2014-06-30 Add$3.69 - $5.13
($4.39)
$ 7.9545%Add 150.00%500,000
NVAXDavid Swensen 2014-03-31 Sold Out -0.23%$4.13 - $6.65
($5.59)
$ 7.9530%Sold Out0
NVAXJean-Marie Eveillard 2014-03-31 Reduce-0.01%$4.13 - $6.65
($5.59)
$ 7.9530%Reduce -75.00%200,000
NVAXDavid Swensen 2013-12-31 Buy 0.23%$2.76 - $5.16
($3.51)
$ 7.9556%New holding25,398
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
($3.51)
$ 7.9556%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
($2.82)
$ 7.9565%New holding573,000
NVAXJean-Marie Eveillard 2013-09-30 Buy 0.01%$2.25 - $3.39
($2.82)
$ 7.9565%New holding800,000
NVAXJean-Marie Eveillard 2011-03-31 Sold Out $2.15 - $2.96
($2.44)
$ 7.9569%Sold Out0
NVAXJean-Marie Eveillard 2010-09-30 Add$2.01 - $2.34
($2.2)
$ 7.9572%Add 25.00%125,000
NVAXJean-Marie Eveillard 2010-06-30 Reduce$2.18 - $2.97
($2.46)
$ 7.9569%Reduce -52.65%100,000
NVAXJean-Marie Eveillard 2009-12-31 Buy 0.01%$2.53 - $4.41
($3.46)
$ 7.9556%New holding250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Herrmann John A IIISVP, General Counsel 2015-01-31Buy9,869$2.28276.32view
Trizzino JohnSVP, Commercial Operations 2015-01-31Buy6,611$3.63136.36view
Hahn Timothy JonSVP, Manufacturing 2015-01-31Buy9,329$2.28276.32view
Wilson Russell PSVP, Business Development 2015-01-31Buy5,050$2.28276.32view
Glenn Gregory MSVP, Research and Development 2015-01-31Buy866$2.28276.32view
PHILLIPS BARCLAY ASVP, CFO 2015-01-31Buy8,388$2.28276.32view
Erck Stanley CCEO and President 2015-01-31Buy6,122$2.28276.32view
EVANS GARY CDirector 2014-12-16Sell46,701$5.7250view
EVANS GARY CDirector 2014-12-12Sell30,000$5.7748.7view
Modi Rajiv I.Director 2014-11-20Sell518,889$5.0270.92view

Press Releases about NVAX :

    Quarterly/Annual Reports about NVAX:

    News about NVAX:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: United States Steel Corp, Tuesday Morning Corp, Novavax Inc. Feb 08 2015 
    comment on NVAX Mar 16 2013 
    comment on NVAX Mar 16 2013 
    Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
    creiter note on NVAX Jan 03 2010 
    Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
    Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
    Novavax Reports Second Quarter 2009 Financial Results Aug 07 2009 

    More From Our Partners
    What Makes Novavax (NVAX) a Strong Sell? - Tale of the Tape Mar 31 2015 - ZACKS

    More From Other Websites
    7 Analyst Stocks Under $10 With Massive Upside Calls Apr 11 2015
    Novavax to Present at the 14th Annual Needham Healthcare Conference Apr 08 2015
    After-hours buzz: Synnex, Dyax, Novavax & more Mar 31 2015
    Novavax Announces Closing of Public Offering Mar 31 2015
    What Makes Novavax (NVAX) a Strong Sell? - Tale of the Tape Mar 31 2015
    Novavax Presents New Data From Non-Human Primate Ebola Challenge at the 7th International Symposium... Mar 28 2015
    NOVAVAX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Mar 27 2015
    Novavax Gives Wall Street Underwriters A Sweet Deal Mar 27 2015
    Novavax Prices Public Offering of Common Stock Mar 26 2015
    Novavax (NVAX) Stock Declines Today After Announcing $175 Million Public Stock Offering Mar 25 2015
    Novavax Announces Proposed Public Offering of Common Stock Mar 24 2015
    FDA panel to discuss Ebola vaccine development in May Mar 18 2015
    Apple CEO Tim Cook surprises Jim Mar 12 2015
    Novavax Appoints Brian Rosen as Vice President, Government Affairs Mar 10 2015
    NOVAVAX INC Financials Mar 05 2015
    10-K for Novavax, Inc. Mar 02 2015
    NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 27 2015
    NOVAVAX INC Files SEC form 10-K, Annual Report Feb 27 2015
    Novavax reports 4Q loss Feb 27 2015
    Novavax reports 4Q loss Feb 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK